TRDA
Azenta Announces the Election of Dipal Doshi to Its Board of Directors
时间:2025-01-31 05:05:07 市场: 美股 综合
Entrada Therapeutics, Inc. Q3 Income From Operations USD -21.658 Million
时间:2024-11-05 20:00:00 市场: 综合 美股
Entrada Therapeutics Promotes Natarajan Sethuraman, Phd, to President of Research and Development
时间:2024-09-24 19:00:01 市场: 综合 美股